Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals ...

The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 12,155 calls trading, 1.0x expected, and implied vol increasing almost 2 ...

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...

Key Takeaways The S&P 500 advanced 0.6% on Wednesday, Jan. 22, 2025, following the announcement of major AI investments and a ...

S&P 500 and Dow Jones continued to advance, boosted by strong earnings reports. President Trump announces major AI investment drive called Stargate. The Dow Jones has risen approximately 6% since ...

Government funding, AI-driven healthcare, and a bold new vision--Moderna is at the center of biotech's next big revolution.